We are live on ! Find out more
MVG

Madrona Venture Group Portfolio holdings

AUM $22.1M
1-Year Est. Return 86.9%
This Fund
S&P 500
This Quarter Est. Return
+13.17%
1 Year Est. Return
+86.9%
3 Year Est. Return
+233.1%
5 Year Est. Return
+22.16%
10 Year Est. Return
AUM
$12.6M
AUM Growth
-$15.9M
Cap. Flow
-$16.7M
Cap. Flow %
-132.46%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
Reduced
Closed
1

Top Buys

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$329K

Top Sells

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$17M

Sector Composition

Rank Sector Weight
1 Technology 61.64%
2 Healthcare 38.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PATH icon
1
UiPath
PATH
$9.5B
$7.78M 61.64%
607,673
NAUT icon
2
Nautilus Biotechnolgy
NAUT
$115M
$4.36M 34.58%
6,020,770
DNA icon
3
Ginkgo Bioworks
DNA
$489M
$477K 3.78%
+42,430
New +$329K
SNOW icon
4
Snowflake
SNOW
$114B
-116,610
Closed -$17M

Similar funds

Madrona Venture Group's Q2 2025 Portfolio in Review

As of Q2 2025, Madrona Venture Group held 4 positions worth $12.6M, down 56% from $28.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Madrona Venture Group withdrew a net $16.7M in Q2 2025, closing 1 position. Its most notable exit was Snowflake, an estimated $17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 62% of assets, down from 82% a quarter earlier, followed by Healthcare.

Against the trend, Madrona Venture Group opened a new position in Ginkgo Bioworks worth $477K.

  • Madrona Venture Group's largest Q2 2025 buy was Ginkgo Bioworks: 42,430 shares worth $477K.
  • Madrona Venture Group fully exited Snowflake in Q2 2025, selling an estimated $17M.
  • Madrona Venture Group's ten largest holdings make up 100% of its $12.6M portfolio in Q2 2025.
  • Madrona Venture Group opened 1 new position and closed 1 in Q2 2025.
  • Madrona Venture Group's portfolio value fell 56% quarter-over-quarter to $12.6M.

Based on Madrona Venture Group's 13F filing for Q2 2025, filed 11 Aug 2025.